Spectrum of mutations in Gitelman syndrome

Area of Science:

• Genetics
• Molecular Biology
• Nephrology

Background:

• Gitelman syndrome (GS) is a rare genetic disorder affecting kidney salt transport.
• Mutations in the SLC12A3 gene, encoding the thiazide-sensitive NaCl cotransporter (NCC), are the primary cause of GS.
• A significant portion of suspected GS cases remain undiagnosed, suggesting other genetic factors may be involved.

Purpose of the Study:

• To investigate the spectrum of SLC12A3 gene mutations in a large cohort of patients with suspected Gitelman syndrome.
• To identify novel mutations and characterize the frequency of large genomic rearrangements.
• To enhance the genetic diagnosis of Gitelman syndrome.

Main Methods:

• Direct sequencing of genomic DNA from 448 unrelated patients with suspected GS.
• Multiplex ligation-dependent probe amplification (MLPA) to detect large genomic rearrangements (deletions and duplications).
• Confirmation of identified rearrangements using a secondary technique.

Main Results:

• Identified 172 distinct SLC12A3 mutations in 448 patients, with 100 being previously unreported.
• Diagnosed GS in 70% of patients with two identified mutations, 18% with one mutation, and 12% with no detectable mutation.
• Detected large genomic rearrangements (9 deletions, 2 duplications) in 24 out of 51 heterozygous patients using MLPA, accounting for 6% of all identified mutations.

Conclusions:

• Missense mutations are the most common type, accounting for approximately 59% of GS mutations.
• Large genomic rearrangements, often caused by recombination between Alu sequences or nonhomologous end-joining, represent a significant cause of GS.
• Comprehensive genetic analysis, including detection of large rearrangements, is crucial for accurate Gitelman syndrome diagnosis.